Core Viewpoint - The Trump administration announced it does not plan to impose tariffs on imported generic drugs, despite previous discussions about tariffs on most pharmaceuticals [1] Group 1: Tariff Decisions - The Trump administration has been weighing the imposition of tariffs on a majority of drugs sold in the U.S. [1] - On October 1, Trump announced a 100% import tariff on all brand-name or patented drugs, but did not mention generic drugs [1] - The White House spokesperson stated that the government is not actively discussing tariffs on generic drugs under Section 232 [1] Group 2: Future Considerations - The decision regarding tariffs on generic drugs is not final and may change in the coming weeks [1] - Most brand-name drugs available in the U.S. are produced in Europe or domestically [1] - The EU-U.S. trade agreement signed in August sets the maximum tariff rate for pharmaceuticals at 15% [1]
特朗普关税政策转弯，暂不加征仿制药关税
Shang Wu Bu Wang Zhan·2025-10-09 16:55